This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation

Sponsored by Adrien Schwitzguebel

About this trial

Last updated 4 years ago

Study ID

ECRB_Conservative

Status

Unknown status

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 65 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

This study evaluates the effect of platelet-rich plasma (PRP) use during needling of the extensor carpalis radialis brevis tendon, after failure of proper reeducation including focal extra-corporal shockwave therapy (ESWT). Half of the patients with receive PRP and needling, and half of the patients will receive needling alone. During the reeducation, the clinical evaluation will be monitored and reported as in a case series.

What are the participation requirements?

Yes

Inclusion Criteria

- Lesion of the ECRB tendon on ultrasonography ([hypoechogenic area during rest OR hypoechogenic area during active contraction, OR compressibility of the tendon OR doppler signal] AND [positive sonopalpation])

- Failure to rehabilitation program including shockwave therapy defined as the need for the patient undergoing additional therapies

No

Exclusion Criteria

- Presence on ultrasound of an isolated lesion of the superficial epicondylar tendons as described above, with intact ECRB

- Presence on ultrasound of any of: radiohumeral synovial material; interruption of the lateral collateral ligament; radial nerve entrapment, i.e. under the arcade of Frohse; osteochondral lesion; joint effusion. Note: calcic enthesophytes are not considered as an exclusion criteria

- Clinical presence of cervicobrachialgia, or pain irradiating into the hand

- Corticosteroids: oral intake or infiltration on the last 3 months

- Proximal radius fracture history

- Active inflammatory rheumatic disorders

- Diabetes mellitus

- Immunocompromized status

- Allergy to local anesthetics

- Bleeding disorders or current anticoagulation therapy

- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiopulmonary significant insufficiency, etc.)

- Known or suspected non-compliance, drug or alcohol abuse

- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

- Participation in another study with investigational drug within the 30 days preceding and during the present study

- Previous enrolment into the current study

- Enrolment of the investigator, his/her family members, employees and other dependent persons